Phase II study of induction gemcitabine and S-1 followed by chemoradiotherapy and systemic chemotherapy using S-1 for locally advanced pancreatic cancer

被引：0

作者：

Kentaro Sudo

Ryusuke Hara

Kazuyoshi Nakamura

Emiri Kita

Akiko Tsujimoto

Taketo Yamaguchi

机构：

[1] Chiba Cancer Center,Department of Gastroenterology

[2] Chiba Cancer Center,Department of Radiation Oncology

来源：

Cancer Chemotherapy and Pharmacology | 2017年 / 80卷

关键词：

Pancreatic cancer; Gemcitabine; S-1; Chemoradiotherapy; Induction chemotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：195 / 202

页数：7

共 50 条

[31] A Phase I Study of S-1-based Concurrent Chemoradiotherapy Followed by Gemcitabine and S-1 in Metastatic Pancreatic Adenocarcinoma
Yang, Shih-Hung
Shao, Yu-Yun
Lin, Chia-Chi
Kuo, Sung-Hsin
Cheng, Ann-Lii
Yeh, Kun-Huei
ANTICANCER RESEARCH, 2018, 38 (08) : 4805 - 4812
[32] A phase II multicentric trial of combined chemotherapy with gemcitabine plus S-1 in patients with advanced pancreatic cancer
Ohkawa, S.
Amano, A.
Ueno, M.
Miyakawa, K.
Sugimori, K.
Tanaka, K.
Kida, M.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[33] A multicenter phase II study of gemcitabine and S-1 combination chemotherapy in patients with unresectable pancreatic cancer
Oh, Do-Youn
Cha, Yongjun
Choi, In-Sil
Yoon, So-Young
Choi, In Keun
Kim, Jee Hyun
Oh, Sang Cheul
Kim, Chang Duck
Kim, Jae Sun
Bang, Yung-Jue
Kim, Yeul Hong
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (03) : 527 - 536
[34] Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
Ueno, Hideki
Ioka, Tatsuya
Ikeda, Masafumi
Ohkawa, Shinichi
Yanagimoto, Hiroaki
Boku, Narikazu
Fukutomi, Akira
Sugimori, Kazuya
Baba, Hideo
Yamao, Kenji
Shimamura, Tomotaka
Sho, Masayuki
Kitano, Masayuki
Cheng, Ann-Lii
Mizumoto, Kazuhiro
Chen, Jen-Shi
Furuse, Junji
Funakoshi, Akihiro
Hatori, Takashi
Yamaguchi, Taketo
Egawa, Shinichi
Sato, Atsushi
Ohashi, Yasuo
Okusaka, Takuji
Tanaka, Masao
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (13) : 1640 - +
[35] A PHASE II TRIAL OF DEFINITIVE CHEMORADIOTHERAPY WITH S-1 AND CISPLATIN FOR LOCALLY ADVANCED OESOPHAGEAL CANCER
Iwase, H.
Shimada, M.
Tsuzuki, T.
Ryuge, N.
Kida, Y.
Kato, B.
Esaki, M.
Tanaka, Y.
Urata, N.
ANNALS OF ONCOLOGY, 2012, 23 : 225 - 226
[36] Phase I/II study of gemcitabine plus S-1 with concurrent radiotherapy in patients of unresectable locally advanced pancreatic cancer
Ioka, Tatsuya
Katayama, Kazuhiro
Ishida, Nobuko
Sueyoshi, Hironari
Takada, Ryoji
Yamai, Takuo
Fukutake, Nobuyasu
Ashida, Reiko
Akita, Hirofumi
Takahashi, Hidenori
Kawaguchi, Yoshifumi
Konishi, Koji
Teshima, Teruki
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
[37] Updated results of a phase II study of gemcitabine, erlotinib, and S-1 in patients with advanced pancreatic cancer
Han, B.
Kim, H. S.
Choi, D. R.
Shim, B. Y.
Lee, K. H.
Kim, J. W.
Kim, J. H.
Kim, H. Y.
Song, H.
Zang, D. Y.
ANNALS OF ONCOLOGY, 2017, 28
[38] A multicenter phase II study of gemcitabine plus S-1 chemotherapy for advanced biliary tract cancer
Arima, S.
Shimizu, K.
Okamoto, T.
Toki, S.
Kasuga, A.
Kitamura, H.
Takasu, A.
Nagashima, F.
Sugiyama, M.
Furuse, J.
EUROPEAN JOURNAL OF CANCER, 2013, 49 : S627 - S627
[39] A Multicenter Phase II Study of Gemcitabine plus S-1 Chemotherapy for Advanced Biliary Tract Cancer
Arima, Shiho
Shimizu, Kyoko
Okamoto, Tomoyoshi
Toki, Masao
Suzuki, Yutaka
Okano, Naohiro
Naruge, Daisuke
Kawai, Kirio
Kobayashi, Takaaki
Kasuga, Akiyoshi
Kitamura, Hiroshi
Takasu, Atuko
Nagashima, Fumio
Sugiyama, Masanori
Furuse, Junji
ANTICANCER RESEARCH, 2017, 37 (02) : 909 - 914
[40] A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer
Morizane, Chigusa
Okusaka, Takuji
Furuse, Junji
Ishii, Hiroshi
Ueno, Hideki
Ikeda, Masafumi
Nakachi, Kohei
Najima, Mina
Ogura, Takashi
Suzuki, Eiichiro
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (02) : 313 - 319

← 1 2 3 4 5 →